000 01237 a2200325 4500
005 20250517225007.0
264 0 _c20190409
008 201904s 0 0 eng d
022 _a1474-4457
024 7 _a10.1016/S1473-3099(18)30340-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWhiley, David M
245 0 0 _aGenetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin.
_h[electronic resource]
260 _bThe Lancet. Infectious diseases
_c07 2018
300 _a717-718 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aAzithromycin
_xtherapeutic use
650 0 4 _aCeftriaxone
_xtherapeutic use
650 0 4 _aDrug Resistance, Bacterial
_xgenetics
650 0 4 _aGonorrhea
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aNeisseria gonorrhoeae
_xdrug effects
700 1 _aJennison, Amy
700 1 _aPearson, Julie
700 1 _aLahra, Monica M
773 0 _tThe Lancet. Infectious diseases
_gvol. 18
_gno. 7
_gp. 717-718
856 4 0 _uhttps://doi.org/10.1016/S1473-3099(18)30340-2
_zAvailable from publisher's website
999 _c28602722
_d28602722